USAA’s Residential Re 2014-2 cat bond prices just below mid-point

Share

U.S. primary insurer USAA’s Residential Reinsurance 2014 Ltd. (Series 2014-2) catastrophe bond transaction has now been priced, with sources telling us that the coupon has been set at 4.8% which is just slightly below the mid-point of initial guidance.

The transaction sees Residential Reinsurance 2014 Ltd. issuing a single Class 4 tranche of $100m of notes to provide USAA with a source of reinsurance protection on an indemnity trigger and per-occurrence basis and with a four-year term to December 2018. The underlying covered perils are certain of USAA’s U.S. tropical storm, earthquake, severe thunderstorm, winter storm, wildfire, volcanic eruption and meteorite impact exposures.

The $100m of Residential Re 2014-2 notes launched to investors with a coupon guide range of 4.5% to 5.25%, which was subsequently narrowed to 4.75% to 5% towards the mid-point of the initial range.

We understand that final pricing sees the Residential Re 2014-2 notes set to pay investors a coupon of 4.8% above the yield of the collateral investments. At this leave, with an expected loss of 1.61%, the deals multiple will be 2.98X.

This catastrophe bond is scheduled to reach settlement in the first week of December. We will update you once it has completed. You can read all about Residential Reinsurance 2014 Ltd. (Series 2014-2) in our cat bond Deal Directory.

———————————————————————
Artemis catastrophe bond ILS DashboardAnalyse catastrophe bond market issuance using the Artemis Dashboard and Charts.

We’ve tracked more than 650 cat bonds and related ILS transactions since 1996, all of which are included in our extensive Deal Directory.

Use the Artemis Dashboard and our Cat Bond Market Charts to analyse this market!

Print Friendly, PDF & Email

Artemis Newsletters and Email Alerts

Receive a regular weekly email newsletter update containing all the top news stories, deals and event information

  • This field is for validation purposes and should be left unchanged.

Receive alert notifications by email for every article from Artemis as it gets published.

Read previous post:
Medical diagnostic tool company to invest in reinsurance and ILS

The range of investors who are targeting the insurance-linked securities (ILS) and reinsurance sectors as an investment asset class, or...

Close